STOCK TITAN

[Form 3] ImageneBio, Inc. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

ImageneBio, Inc. filed an Initial Statement of Beneficial Ownership (Form 3) for director Stephen Hui Wang relating to an event on 07/25/2025. The filing states that no securities are beneficially owned by the reporting person. The Form 3 was executed via Power of Attorney and signed by Erin Butler, Attorney-in-Fact on 10/10/2025. The filing notes it was submitted late due to delays obtaining the reporting person’s EDGAR codes.

ImageneBio, Inc. ha presentato una Dichiarazione iniziale di proprietà beneficiaria (Modulo 3) per il consigliere Stephen Hui Wang relativo a un evento del 25/07/2025. La dichiarazione attesta che nessun titolo è posseduto in modo beneficiario dalla persona che presenta il referto. Il Modulo 3 è stato eseguito mediante Procuratore e firmato da Erin Butler, Procuratore-in-fatto il 10/10/2025. Si segnala che la presentazione è stata inviata in ritardo a causa di ritardi nell’ottenere i codici EDGAR della persona che presenta il referto.

ImageneBio, Inc. presentó una Declaración inicial de propiedad beneficiosa (Formulario 3) para el director Stephen Hui Wang relacionada con un evento del 25/07/2025. La presentación indica que ninguna seguridad es propiedad de manera beneficiosa por la persona que informa. El Formulario 3 se ejecutó mediante Poder notarial y fue firmado por Erin Butler, apoderado el 10/10/2025. La presentación señala que fue presentada con retraso debido a retrasos en obtener los códigos EDGAR de la persona informante.

ImageneBio, Inc.는 이사 Stephen Hui Wang와 관련된 07/25/2025의 사건에 대해 실질적 소유권 선언서(폼 3)를 제출했습니다. 보고자는 귀속 증권이 아무 것도 보유되지 않음을 명시합니다. Form 3은 위임장을 통해 실행되었으며, Erin Butler, 대리인2025-10-10에 서명했습니다. 보고서가 EDGAR 코드 획득 지연으로 인해 지연 제출되었다고 기재되어 있습니다.

ImageneBio, Inc. a déposé une Déclaration initiale de propriété bénéficiaire (Formulaire 3) pour le directeur Stephen Hui Wang relative à un événement du 25/07/2025. Le dépôt indique que aucune valeur mobilière n'est détenue de manière bénéficiaire par la personne déclarant. Le Formulaire 3 a été exécuté par procuration et signé par Erin Butler, mandataire le 10/10/2025. Le dépôt précise qu'il a été soumis en retard en raison de retards pour obtenir les codes EDGAR de la personne déclarante.

ImageneBio, Inc. hat eine Erstangabe zum begünstigten Eigentum (Formular 3) für den Direktor Stephen Hui Wang im Zusammenhang mit einem Ereignis am 25.07.2025 eingereicht. Die Einreichung gibt an, dass keine Wertpapiere vom meldenden Person begünstigt gehalten werden. Das Formular 3 wurde per Vollmacht ausgeführt und von Erin Butler, Bevollmächtigte/r am 10.10.2025 unterzeichnet. Die Einreichung vermerkt, dass sie aufgrund von Verzögerungen beim Beschaffen der EDGAR-Codes der meldenden Person verspätet eingereicht wurde.

ImageneBio, Inc. قد قدمت بيان الملكية المستفيدة الأولي (النموذج 3) لمدير Stephen Hui Wang متعلق بحدث بتاريخ 07/25/2025. يفيد الإيداع أن لا توجد أسهم مملوكة بشكل مستفاد من قبل الشخص المبلغ. تم تنفيذ النموذج 3 عبر تفويض ووقعته Erin Butler، الوكيل المعتمد في 10/10/2025. وتشير الإيداع إلى أنه تم تقديمه متأخراً بسبب تأخر الحصول على رموز EDGAR الخاصة بالشخص المبلغ.

ImageneBio, Inc. 已提交一份 初始受益所有权声明(表格 3),涉及董事 Stephen Hui Wang07/25/2025 的事件。该申报称报告人并无实际持有的证券。表格 3 通过 授权书 执行,并由 Erin Butler,授权代理人2025-10-10 签署。申报还指出,由于获取报告人的 EDGAR 代码延迟,提交时间延误。

Positive
  • None.
Negative
  • None.

Insights

Form 3 shows a director with no reported ownership and a delayed filing.

The Form 3 documents that Stephen Hui Wang is a director and did not beneficially own any company securities as of the reported event date 07/25/2025. This is a simple disclosure of status rather than a transaction.

Timing is a governance consideration: the filing was noted as late because of EDGAR code delays and was signed on 10/10/2025. Investors may monitor subsequent Section 16 filings for any future acquisitions or dispositions that would change ownership status within the standard reporting windows.

ImageneBio, Inc. ha presentato una Dichiarazione iniziale di proprietà beneficiaria (Modulo 3) per il consigliere Stephen Hui Wang relativo a un evento del 25/07/2025. La dichiarazione attesta che nessun titolo è posseduto in modo beneficiario dalla persona che presenta il referto. Il Modulo 3 è stato eseguito mediante Procuratore e firmato da Erin Butler, Procuratore-in-fatto il 10/10/2025. Si segnala che la presentazione è stata inviata in ritardo a causa di ritardi nell’ottenere i codici EDGAR della persona che presenta il referto.

ImageneBio, Inc. presentó una Declaración inicial de propiedad beneficiosa (Formulario 3) para el director Stephen Hui Wang relacionada con un evento del 25/07/2025. La presentación indica que ninguna seguridad es propiedad de manera beneficiosa por la persona que informa. El Formulario 3 se ejecutó mediante Poder notarial y fue firmado por Erin Butler, apoderado el 10/10/2025. La presentación señala que fue presentada con retraso debido a retrasos en obtener los códigos EDGAR de la persona informante.

ImageneBio, Inc.는 이사 Stephen Hui Wang와 관련된 07/25/2025의 사건에 대해 실질적 소유권 선언서(폼 3)를 제출했습니다. 보고자는 귀속 증권이 아무 것도 보유되지 않음을 명시합니다. Form 3은 위임장을 통해 실행되었으며, Erin Butler, 대리인2025-10-10에 서명했습니다. 보고서가 EDGAR 코드 획득 지연으로 인해 지연 제출되었다고 기재되어 있습니다.

ImageneBio, Inc. a déposé une Déclaration initiale de propriété bénéficiaire (Formulaire 3) pour le directeur Stephen Hui Wang relative à un événement du 25/07/2025. Le dépôt indique que aucune valeur mobilière n'est détenue de manière bénéficiaire par la personne déclarant. Le Formulaire 3 a été exécuté par procuration et signé par Erin Butler, mandataire le 10/10/2025. Le dépôt précise qu'il a été soumis en retard en raison de retards pour obtenir les codes EDGAR de la personne déclarante.

ImageneBio, Inc. hat eine Erstangabe zum begünstigten Eigentum (Formular 3) für den Direktor Stephen Hui Wang im Zusammenhang mit einem Ereignis am 25.07.2025 eingereicht. Die Einreichung gibt an, dass keine Wertpapiere vom meldenden Person begünstigt gehalten werden. Das Formular 3 wurde per Vollmacht ausgeführt und von Erin Butler, Bevollmächtigte/r am 10.10.2025 unterzeichnet. Die Einreichung vermerkt, dass sie aufgrund von Verzögerungen beim Beschaffen der EDGAR-Codes der meldenden Person verspätet eingereicht wurde.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Wang Stephen Hui

(Last) (First) (Middle)
C/O IMAGENEBIO, INC.
12526 HIGH BLUFF DRIVE, SUITE 345

(Street)
SAN DIEGO CA 92130

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/25/2025
3. Issuer Name and Ticker or Trading Symbol
ImageneBio, Inc. [ IMA ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Exhibit 24 - Power of Attorney. This Form 3 is being filed late due to delays in obtaining the reporting person's EDGAR codes.
No securities are beneficially owned.
/s/ Erin Butler, Attorney-in-Fact 10/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 3 filed for ImageneBio (IMA) disclose?

The Form 3 discloses that director Stephen Hui Wang reported no securities beneficially owned as of the event date 07/25/2025.

When was the Form 3 for IMA executed and signed?

The Form 3 notes the event date 07/25/2025 and was signed by Erin Butler, Attorney-in-Fact on 10/10/2025.

Why was the Form 3 filed late?

The filing states it was late because of delays in obtaining the reporting person's EDGAR codes.

Does the Form 3 report any derivative or non-derivative holdings?

No. The filing explicitly states no securities are beneficially owned, and no derivative or non-derivative holdings are listed.

Who is the reporting person on this Form 3 for IMA?

The reporting person is Stephen Hui Wang, listed as a Director of ImageneBio, Inc.
ImageneBio

NASDAQ:IMA

IMA Rankings

IMA Latest News

IMA Latest SEC Filings

IMA Stock Data

92.03M
9.21M
14.24%
33.27%
0.09%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
BOSTON